Revance Therapeutics, Inc. announced the appointment of Erica Jordan, Senior Vice President of Commercial to Chief Commercial Officer (CCO), Aesthetics. As CCO, Erica will have global responsibility for all aesthetics commercial activity including commercial strategy, sales and marketing, branding, loyalty and engagement. Ms. Jordan joined Revance earlier this year as Senior Vice President of Commercial, bringing 25 years of marketing, sales management, commercial strategy, commercial operations and management experience at leading global healthcare companies.

Prior to joining Revance, she served as President of the Metrex division at Envista Holdings, where she developed and executed a successful commercial strategy and implemented operational efficiencies to support double-digital growth. There, she also held the role of Senior Vice President, Sales & Marketing for the Ormco division where she successfully launched multiple new products and enabled significant market share growth for the flagship product categories. Before Envista Holdings, Ms. Jordan served as Vice President, Global Marketing for Change Healthcare where she developed and executed the commercial strategy for the first-ever cloud-based radiology enterprise imaging platform.

She has held several marketing, commercial and operational leadership roles at Phillips Healthcare, including her role as Vice President, Senior General Manager, where she built the commercial team and the go-to-market strategy for the newly acquired women?s healthcare business. In addition, she held senior leadership roles at Fujifilm Medical Systems, Siemens Medical Solutions and GE Healthcare. Ms. Jordan received her B.S. in Marketing and Finance from the University of Wisconsin-Milwaukee and is an active member of the Women Business Leaders of the US Health Care Industry Foundation.